The Yin and Yang of Cholesteryl Ester Transfer Protein in Cardiovascular Disease

被引：10

作者：

Shah, Prediman K. ^{[1
,2
]}

机构：

[1] Cedars Sinai Med Ctr, Div Cardiol, Oppenheimer Atherosclerosis Res Ctr, Los Angeles, CA 90048 USA

[2] Cedars Sinai Med Ctr, Cedars Sinai Heart Inst, Los Angeles, CA 90048 USA

来源：

CIRCULATION | 2009年 / 120卷 / 24期

关键词：

Editorials; atherosclerosis; cholesterol ester transfer proteins; cholesterol; high-density lipoprotein; lipoproteins; prevention; CORONARY-HEART-DISEASE; TORCETRAPIB; RISK; GENE; ATHEROSCLEROSIS; MUTATION; PROGRESSION; FAILURE; WOMEN; MEN;

D O I：

10.1161/CIRCULATIONAHA.109.910133

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2408 / 2410

页数：3

共 50 条

[31] Cholesteryl ester transfer protein and atherogenesis
Tall, A
Sharp, D
Zhong, S
Hayek, T
MasucciMagoulas, L
Rubin, EM
Breslow, JL
ATHEROSCLEROSIS IV: RECENT ADVANCES IN ATHEROSCLEROSIS RESEARCH: THE FOURTH SARATOGA INTERNATIONAL CONFERENCE ON ATHEROSCLEROSIS, 1997, 811 : 178 - 184
[32] Cholesteryl ester transfer protein and atherosclerosis
Inazu, A
Koizumi, J
Mabuchi, H
CURRENT OPINION IN LIPIDOLOGY, 2000, 11 (04) : 389 - 396
[33] Inhibitors of cholesteryl ester transfer protein
不详
DRUG DISCOVERY TODAY, 2001, 6 (06) : 325 - 325
[34] PLASMA CHOLESTERYL ESTER TRANSFER PROTEIN
TALL, AR
JOURNAL OF LIPID RESEARCH, 1993, 34 (08) : 1255 - 1274
[35] CHOLESTERYL ESTER ANALOGS INHIBIT CHOLESTERYL ESTER BUT NOT TRIGLYCERIDE TRANSFER CATALYZED BY THE PLASMA CHOLESTERYL ESTER-TRIGLYCERIDE TRANSFER PROTEIN
BUSCH, SJ
HARMONY, JAK
LIPIDS, 1990, 25 (04) : 216 - 220
[36] USE OF FLUORESCENT CHOLESTERYL ESTER MICROEMULSIONS IN CHOLESTERYL ESTER TRANSFER PROTEIN ASSAYS
BISGAIER, CL
MINTON, LL
ESSENBURG, AD
WHITE, A
HOMAN, R
JOURNAL OF LIPID RESEARCH, 1993, 34 (09) : 1625 - 1634
[37] Pathophysiology and inhibition of cholesteryl ester transfer protein for prevention of cardiovascular diseases: An update
Banerjee, Surojit
De, Abhijit
DRUG DISCOVERY TODAY, 2021, 26 (07) : 1759 - 1764
[38] Cholesteryl ester transfer protein, high density lipoprotein and arterial disease
Barter, PJ
Rye, KA
CURRENT OPINION IN LIPIDOLOGY, 2001, 12 (04) : 377 - 382
[39] Cholesteryl ester transfer protein concentrations predict cardiovascular events in patients with coronary artery disease treated with pravastatin
Marschang, P.
Sandhofer, A.
Ritsch, A.
Fiser, I.
Kvas, E.
Patsch, J. R.
ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 12 - 12
[40] Rationale for cholesteryl ester transfer protein inhibition
Hewing, Bernd
Fisher, Edward A.
CURRENT OPINION IN LIPIDOLOGY, 2012, 23 (04) : 372 - 376

← 1 2 3 4 5 →